Etokimab + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peanut Allergy
Conditions
Peanut Allergy
Trial Timeline
Jan 26, 2017 → Mar 30, 2018
NCT ID
NCT02920021About Etokimab + Placebo
Etokimab + Placebo is a phase 2 stage product being developed by AnaptysBio for Peanut Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT02920021. Target conditions include Peanut Allergy.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03533751 | Phase 2 | Completed |
| NCT03469934 | Phase 2 | Completed |
| NCT02920021 | Phase 2 | Completed |
Competing Products
20 competing products in Peanut Allergy